GST issue haunts chemists across country

Published On 2021-02-27 12:58 GMT | Update On 2021-02-27 12:58 GMT

New Delhi: While medicine sale has taken prime most spot with the Covid-19 pandemic, the issue of GST continues to haunt 9.40 lakh chemists of the country. In this regard, the All India Organization of Chemists and Druggists (AIOCD) has sent a memorandum to the Finance Minister asking her to correct GST anomalies with immediate attention.

The chemist body drew further attention to the discrepancies in the memorandum.

Also Read: Indian Pharma Sees Decline In August 2020, Anti-Infectives, Respiratory Segments See Major Slumps: AIOCD-AWACS Report

J.S.Shinde, President, and Rajiv Singhal General Secretary of the Association of said that despite all the amendments, the inconsistencies in the GST law of the country are not being corrected even due to which there is a lot of anger among the traders.

They added that being public health care chemists and want to maintain the availability of medicines during this crucial Corona period, they will not be involved in any BANDH, however, they warned if the above discrepancies are not taken care of then chemists in the country will also be forced to agitate.

AIOCD further added that it anticipates that the Government will find all the suggestions of the Organization practical and will provide relief to the business by making necessary simplification of GST by giving necessary instructions for the implementation of 'Ease of Doing Business' of the respected Prime Minister.

Also Read: Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medical Dialogues Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

GST issue haunts chemists across country

Similar News

AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice

Fixed Dose Combination of Metformin-Voglibose Now CDSCO Approved

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin

Torrent Pharma Brand Misused in Online Investment Scam, Fake Portals Promising High Returns Busted

Alembic Pharma gets USFDA EIR for 2 API facilities in Panelav

Raid at quack clinic in Telangana, drugs illegally stocked for sale seized

Dr Reddys Labs gets 5 observations from USFDA for Bachupally facility

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility